Welcome to Vascular Specialist

Dr. K. Wayne Johnston

New devices and new minimally invasive procedures are affecting the way that vascular surgery is being practiced.

To address the challenges of keeping up with these and the many other rapid developments in the specialty, the Society for Vascular Surgery and the Elsevier Society News Group have joined forces to produce this newspaper designed to meet the information needs of vascular specialists.

VASCULAR SPECIALIST is the official newspaper of the Society for Vascular Surgery. This bimonthly publication includes sections devoted to the major fields in the specialty.

VASCULAR SPECIALIST will cover the latest advances as presented at key professional meetings around the world. It will follow the latest scientific breakthroughs and opinions in a wide variety of topic areas, including the treatment of aneurysms, peripheral arterial disease and claudication, deep vein thrombosis and pulmonary embolism, carotid disease and stroke, renovascular and mesenteric disease, diabetes and related conditions, as well as venous and lymphatic disease. All of our coverage is designed with a focus on your interests as clinical practitioners.

Together with his associate editors who form our editorial board, medical editor Dr. K. Wayne Johnston will guide the selection of articles that not only inform you but also put the news into perspective.

To bring you VASCULAR SPECIALIST, the SVS will be working with Elsevier Global Medical News (EGMN), an organization with a 40-year history of covering medical news and publishing medical newspapers.

EGMN reporters cover more than 500 medical meetings each year and write about the research developments that appear months or years later in peer-reviewed journals.

In addition to reporting from major medical meetings, VASCULAR SPECIALIST will be drawing on coverage of new device and drug approvals by the Food and Drug Administration, changes in reimbursement by Medicare, and other regulatory issues that affect your practice. A special section on news related to devices, drugs, and their clinical trials will be included in each issue.

As readers of this new publication, you are invited to participate in shaping the tenor of VASCULAR SPECIALIST through your letters to the editor, responses to editorials, and proposals for content that address the rapid changes occurring within vascular surgery and vascular therapies.

Our goal is to provide you with the in-depth, up-to-date information that you need to incorporate new therapeutic concepts into your practice and patient care plan. We also hope to keep you apprised of changes coming from Washington, D.C., that will influence your patients' health care options and the way you do business.

We hope that you will join us in creating a new opportunity for communicating and sharing information and opinion within the specialty.

Please let us know your reaction to this newspaper. We truly want you to think of it as your publication.

Let us know what you liked and disliked, as well as the kinds of articles and topics you would like to see featured in upcoming issues by e-mailing us at VascularSpecialist@vascularsociety.org.

Table of Contents